Screen your AAV production process – From high throughput to scalabilit

Authors

Kathrin Teschner, Sartorius Xell GmbH, Bielefeld, 33689, GermanyFollow
Stefano Boi, Sartorius Stedim Cellca GmbH, 89081 Ulm, Germany
Yi-hsuan Huang, Sartorius Stedim Cellca GmbH, 89081 Ulm, Germany
Vera Ortseifen, Sartorius Xell GmbH, Bielefeld, 33689, Germany
Pia Brinkert, Sartorius Xell GmbH, Bielefeld, 33689, Germany
Alyssa Buve, Sartorius Xell GmbH, Bielefeld, 33689, Germany
Kristin Thiele, Sartorius Stedim Cellca GmbH, 89081 Ulm, Germany
Sandra Klausing, Sartorius Stedim Cellca GmbH, 89081 Ulm, Germany

Conference Dates

February 4 - 8, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Kathrin Teschner, Stefano Boi, Yi-hsuan Huang, Vera Ortseifen, Pia Brinkert, Alyssa Buve, Kristin Thiele, and Sandra Klausing, "Screen your AAV production process – From high throughput to scalabilit" in "Advancing Manufacture of Cell and Gene Therapies VIII", Fernanda Masri, Cytomos, United Kingdom; Carolyn Yeago, CY Solutions LLC, USA; Gargi Maheshwari, BMS, USA; John Moscariello, BMS, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/cell_gene_therapies_viii/31